Morgan Stanley and Goldman Sachs have both lowered their price targets for Bath & Body Works (BBWI), citing potential pressures due to tariffs and other spending concerns. Despite this, both have maintained their recommendations for investors to buy, and the stock has seen some positive movement recently, trading up 4.4% and even surging up to 6.35%. The company delivered a solid performance in Q1, beating earnings estimates and showing a consistent rise in sales year over year. However, there have been some fluctuations, with the stock hitting a 12-month low, dipping by 3.1%, and reporting weak Q2 guidance. A significant leadership change was announced with the appointment of a former Nike executive as the new CEO. Other noteworthy information includes a large volume purchase of put options by investors, a collaboration with Disney to launch a Disney Princess Fragrance Collection, and reaffirmation of the financial guidance for 2025. BBWI also announced dividends and is set for a return to top-line growth. Despite the looming headwinds, the company's stock is considered undervalued by some hedge funds, suggesting a potential buying opportunity.
Bath Body Works BBWI News Analytics from Mon, 30 Sep 2024 07:00:00 GMT to Fri, 20 Jun 2025 20:06:43 GMT -
Rating 4
- Innovation 2
- Information 5
- Rumor -3
